Identification
Personal identification
- Full name
- Cláudia Vitorino-Oliveira
Citation names
- Vitorino-Oliveira, Cláudia
Author identifiers
- Ciência ID
- 9C12-817F-4650
- ORCID iD
- 0009-0009-1541-9465
Languages
| Language | Speaking | Reading | Writing | Listening | Peer-review |
|---|---|---|---|---|---|
| Portuguese (Mother tongue) | |||||
| English | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) |
Education
| Degree | Classification | |
|---|---|---|
|
2025/01/01 - 2029
Ongoing
|
Ciências Farmacêuticas (Doutoramento)
Major in Toxiciologia
Universidade do Porto Faculdade de Farmácia, Portugal
|
|
|
2025/01/29
Concluded
|
Flow Cytometry: from basic knoledge to clinical applications (Curso de Especialização Tecnológica)
Universidade do Porto Faculdade de Farmácia, Portugal
|
20 |
|
2021/09/01 - 2023/11/17
Concluded
|
Bioquímica (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"Nrf2 modulators as pharmacological strategies to tackle the cardiotoxicity of anti-cancer drugs: a cardio-oncology in vitro
study in human cardiac AC16 cells" (THESIS/DISSERTATION)
|
17 |
|
2018/09/10 - 2021/07/20
Concluded
|
Bioquímica (Licenciatura)
Universidade de Aveiro, Portugal
|
15 |
Affiliation
Others
| Category Host institution |
Employer | |
|---|---|---|
| 2024/01/01 - 2029 | PhD student | Unidade de Ciências Biomoleculares Aplicadas, Portugal |
| Universidade do Porto Faculdade de Farmácia, Portugal |
Outputs
Publications
| Conference abstract |
|
| Conference paper |
|
| Conference poster |
|
| Journal article |
|
| Thesis / Dissertation |
|
Activities
Oral presentation
| Presentation title | Event name Host (Event location) |
|
|---|---|---|
| 2025/02/07 | Cardiotoxicity of Sunitinib: Insights into the impact on the autophagy pathway | SPF 2025 55ª reunião da Sociedade Portuguesa de Farmacologia, 43ª reunião de Farmacologia Clínica, 24ª reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
|
| 2024/02 | The cytotoxicity of doxorubicin, sunitinib and bortezomib in AC16 cardiac cells and possible therapeutic options involving redox pathways | SPF 2021 - 54th Meeting of Portuguese Society of Pharmacology, 42nd Meeting of the Clinical Pharmacology and 23rd Meeting
of the Toxixology
(Lisboa, Portugal)
|
| 2023/05/12 | The effect of the glutathione pathway on the cytotoxicity of sunitinib, doxrubicin and bortezomib in AC16 | 16th Meeting of Young Researchers of Univeristy of Porto
Universidade do Porto (Porto, Portugal)
|
| 2023/04/28 | The influence of glutathione pathway modulators on the cytotoxicity of sunitinib, doxorubicin and bortezomib in AC16 cardiac cells | II TOXRUN International Congress 2023
(Porto, Portugal)
|
Supervision
| Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
|---|---|---|
| 2024/01 - Current | Characterization of an In Vitro Model of Human Heart Cells
Co-supervisor
|
Universidade do Porto Departamento de Química e Bioquímica, Portugal
|
Ad Hoc journal article review
| Journal title (ISSN) | Publisher | |
|---|---|---|
| 2023/12 - Current | Heliyon | Elsevier |
Mentoring / Tutoring
| Topic | Student name | |
|---|---|---|
| 2023/06/02 - 2023/06/16 | Student Exchange Programme (SEP) | Alicja Lemanska |
| 2023/06/02 - 2023/06/16 | Student Exchange Programme (SEP) | Maja Cvetanoska |
Distinctions
Award
| 2023 | Oncology & Immunology Poster Session First Prize |
Other distinction
| 2024 | Selected for oral presentation
Scientific Committee of III TOXRUN International congress 2024, Portugal
|
| 2023 | Selected for oral presentation
Scientific Committee of II TOXRUN International congress 2023, Portugal
|
